Peter H. Watson

Overview

Best Publications

• The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups

  Christina Curtis;Christina Curtis;Sohrab P Shah;Suet-Feung Chin;Gulisa Turashvili

  6086
  Citations

• The clonal and mutational evolution spectrum of primary triple-negative breast cancers

  Sohrab P. Shah;Andrew Roth;Rodrigo Goya;Arusha Oloumi

  2232
  Citations

• Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma

  Mauro Castellarin;René L. Warren;J. Douglas Freeman;Lisa Dreolini

  2046
  Citations

• Hypoxia-inducible Expression of Tumor-associated Carbonic Anhydrases

  Charles C. Wykoff;Nigel J. P. Beasley;Peter H. Watson;Kevin J. Turner

  1564
  Citations

• British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus

  Rebecca C Fitzgerald;Massimiliano di Pietro;Krish Ragunath;Yeng Ang

  1442
  Citations

• Information Needs and Decisional Preferences in Women With Breast Cancer

  Lesley F. Degner;Linda J. Kristjanson;David Bowman;Jeffrey A. Sloan

  1402
  Citations

• Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution

  Sohrab P. Shah;Ryan D. Morin;Jaswinder Khattra;Leah Prentice

  1306
  Citations

• Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group Part 2 TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non–Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain Tumors

  Shona Hendry;Roberto Salgado;Thomas Gevaert;Prudence A. Russell;Prudence A. Russell

  897
  Citations

• HIF-1-dependent regulation of hypoxic induction of the cell death factors BNIP3 and NIX in human tumors.

  Heidi M. Sowter;Peter J. Ratcliffe;Peter Watson;Arnold H. Greenberg

  874
  Citations

• Assessing Tumor-infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immunooncology Biomarkers Working Group: Part 1: Assessing the Host Immune Response, TILs in Invasive Breast Carcinoma and Ductal Carcinoma in Situ, Metastatic Tumor Deposits and Areas for Further Research

  Shona Hendry;Roberto Salgado;Thomas Gevaert;Prudence A. Russell;Prudence A. Russell

  800
  Citations

• CD20+ Tumor-Infiltrating Lymphocytes Have an Atypical CD27− Memory Phenotype and Together with CD8+ T Cells Promote Favorable Prognosis in Ovarian Cancer

  Julie S. Nielsen;Rob A. Sahota;Katy Milne;Sara E. Kost

  585
  Citations

• Beware of connective tissue proteins: assignment and implications of collagen absorptions in infrared spectra of human tissues

  Michael Jackson;Lin-P'ing Choo;Lin-P'ing Choo;Peter H. Watson;William C. Halliday

  532
  Citations

• Prognostic Significance of a Novel Hypoxia-Regulated Marker, Carbonic Anhydrase IX, in Invasive Breast Carcinoma

  Stephen K. Chia;Charles C. Wykoff;Peter H. Watson;Cheng Han

  532
  Citations

• Frequent somatic mutations in PTEN and TP53 are mutually exclusive in the stroma of breast carcinomas.

  Keisuke Kurose;Kristie Gilley;Satoshi Matsumoto;Peter H. Watson

  529
  Citations

• Systematic Analysis of Immune Infiltrates in High-Grade Serous Ovarian Cancer Reveals CD20, FoxP3 and TIA-1 as Positive Prognostic Factors

  Katy Milne;Martin Köbel;Steven E. Kalloger;Rebecca O. Barnes

  481
  Citations

• Do patients benefit from participating in medical decision making? Longitudinal follow-up of women with breast cancer.

  Thomas F. Hack;Lesley F. Degner;Peter Watson;Luella Sinha

  468
  Citations

• Tumor-infiltrating lymphocytes expressing the tissue resident memory marker CD103 are associated with increased survival in high-grade serous ovarian cancer

  John R. Webb;Katy Milne;Peter Watson;Ronald J. deLeeuw

  464
  Citations

• Altered Estrogen Receptor α and β Messenger RNA Expression during Human Breast Tumorigenesis

  Etienne Leygue;Helmut Dotzlaw;Peter H. Watson;Leigh C. Murphy

  440
  Citations

• Tumor-infiltrating lymphocytes predict response to anthracycline-based chemotherapy in estrogen receptor-negative breast cancer

  Nathan R West;Katy Milne;Pauline T Truong;Nicol Macpherson

  424
  Citations

• Somatostatin receptors in primary human breast cancer: quantitative analysis of mRNA for subtypes 1–5 and correlation with receptor protein expression and tumor pathology

  U. Kumar;S. I. Grigorakis;H. L. Watt;R. Sasi

  390
  Citations